AzTrials
AzTrials

Healthy Young AdultsNCT05407259

Investigating the Inverted-U Relationship Between Cognitive Performance and Plasma Epinephrine

A study testing Resistance exercise in people with Healthy Young Adults, run by National Taiwan Normal University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Abstract Although acute resistance exercise has been suggested to enhance inhibitory control, a critical component of executive function, the mechanism by which acute exercise influences inhibitory control is unclear and there are methodological limitations in previous empirical studies. Read more about this study

Who is it for?
Ages 20 to 40 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy Young Adults
What is being tested?
Resistance exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
1 Jun 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy young male aged 18-40 years;
  • recreational resistance-trained (≥ 1 time/week for the previous 6 months);
  • free from cardiovascular, cerebrovascular, and neurological disorders and other chronic diseases;
  • free from any medical condition listed on the 2014 update of the Physical Activity Readiness Questionnaire (PAR-Q+);
  • non-smoker; and
  • normal or corrected-to-normal vision.

Who cannot join

  • athlete trained in a competitive sports team or engaging in exercise for more than 20 hours/week;
  • unable to perform any of the intervention exercises (barbell squat, press, and deadlift); or
  • color blind

Trial locations and contacts

No sites are listed yet.

Ting-Yu Lin, B.A. contact

+886975211701

leo850922@gmail.com

About this study

Official title: Investigating the Inverted-U Relationship Between Cognitive Performance and Plasma Epinephrine: A Registered Report of a Four-arm Crossover Randomized Controlled Trial

Abstract Although acute resistance exercise has been suggested to enhance inhibitory control, a critical component of executive function, the mechanism by which acute exercise influences inhibitory control is unclear and there are methodological limitations in previous empirical studies. According to the locus coeruleus-norepinephrine (LC-NE) theory, the activity of the LC, the major releaser of NE in the brain, regulates inhibitory control. Because there is reciprocal communication between circulating epinephrine and the LC. Plasma epinephrine is chosen as the index of LC-NE activity. However, only one study in acute exercise-inhibitory control measured the plasma epinephrine. Therefore, this registered report aims to extend its findings by a four-arm crossover randomized controlled design with three different intensities, using free-weight, multiple-joint, and structural resistance exercises. Moreover, most studies showed some methodological limitations such as failing to report the process of randomization, implementing a familiarization of resistance exercise before the maximal strength test, and publishing the protocol. Without a transparent report on how the participants were allocated, the results were at risk of bias. Without a familiarization of resistance exercise, the maximal muscle strength was likely to be underestimated. Without publishing the protocol before data collection, these findings were threatened by undetected researchers' degrees of freedom such as HARKing (hypothesizing after the results are known), cherry picking, and p-hacking. This registered report will address the limitations of previous studies by incorporating cognitive and resistance exercise familiarization, transparently reporting the randomization process, and submitting it as a registered report.

Being tested
Resistance exercise
Keywords
Resistance Training, Kinesiology, Applied, Cognitive Neuroscience, Psychology, Sports, Cognitive Psychology, Psychophysiology, Exercise, Circuit-Based Exercise
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance exerciseBehavioural

    Also called Resistance training

    There will be four conditions (three exercises and one control) on visits 3-6. For the three exercise conditions, all training parameters except intensity will be the same. The sets in high, moderate, and low intensity correspond to the rate of perceived exertion (0-10 scale) 7-9, 5-6, and 3-4, respectively. Therefore, the participants will perform 5 repetitions barbell squat, barbell press, and barbell deadlift with 8RM (78% 1RM), 11RM (72% 1RM), and 16RM (65% 1RM) for 3 sets

Study groups in NCT05407259
Study groupRoleWhat they receive
Control conditionNo interventionDuring the control condition, participants will be asked to read a book related to exercise for approximately 40 minutes.
Low-intensity barbell resistance exerciseExperimentalExercise: Barbell squat, barbell press, and barbell deadlift Number of sets: 3 Number of repetitions: 5 Intensity: 65% 1RM Training method: Circuit training (Squat set 1 ➔ Press set 1 ➔ Deadlift set 1 ➔ Squat set 2 ➔ Press set 2 ➔ Deadlift set 2 ➔ Squat set 3 ➔ Press set 3 ➔ Deadlift set 3) Rest interval between exercises and sets: ~3 minutes (Warm-up: 1 set of 5 repetitions for each exercise at 50% 1RM)
Receives: Behavioral: Resistance exercise
Moderate-intensity barbell resistance exerciseExperimentalExercise: Barbell squat, barbell press, and barbell deadlift Number of sets: 3 Number of repetitions: 5 Intensity: 72% 1RM Training method: Circuit training (Squat set 1 ➔ Press set 1 ➔ Deadlift set 1 ➔ Squat set 2 ➔ Press set 2 ➔ Deadlift set 2 ➔ Squat set 3 ➔ Press set 3 ➔ Deadlift set 3) Rest interval between exercises and sets: ~3 minutes (Warm-up: 1 set of 5 repetitions for each exercise at 50% 1RM)
Receives: Behavioral: Resistance exercise
High-intensity barbell resistance exerciseExperimentalExercise: Barbell squat, barbell press, and barbell deadlift Number of sets: 3 Number of repetitions: 5 Intensity: 78% 1RM Training method: Circuit training (Squat set 1 ➔ Press set 1 ➔ Deadlift set 1 ➔ Squat set 2 ➔ Press set 2 ➔ Deadlift set 2 ➔ Squat set 3 ➔ Press set 3 ➔ Deadlift set 3) Rest interval between exercises and sets: ~3 minutes (Warm-up: 1 set of 5 repetitions for each exercise at 50% 1RM)
Receives: Behavioral: Resistance exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inhibitory control (change between baseline and 5 minutes after intervention/control)

    The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 5 minutes after (post-task) intervention/control.

  2. Inhibitory control (change between baseline and 20 minutes after intervention/control)

    The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 20 minutes after (post-task) intervention/control.

  3. Inhibitory control (change between baseline and 35 minutes after intervention/control)

    The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 35 minutes after (post-task) intervention/control.

  4. Inhibitory control (change between baseline and 50 minutes after intervention/control)

    The Inhibitory control (Stroop interference score) will be the mean incongruent reaction time minus the mean congruent reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 50 minutes after (post-task) intervention/control.

  5. Information processing speed (change between baseline and 5 minutes after intervention/control)

    The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 5 minutes after intervention/control.

  6. Information processing speed (change between baseline and 20 minutes after intervention/control)

    The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 20 minutes after intervention/control.

  7. Information processing speed (change between baseline and 35 minutes after intervention/control)

    The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 35 minutes after intervention/control.

  8. Information processing speed (change between baseline and 50 minutes after intervention/control)

    The Information processing speed will be the mean simple reaction time. Lower scores mean a better outcome.

    Measured: Baseline (before intervention) and 50 minutes after intervention/control.

Secondary outcomes (5)
  1. Epinephrine (change between baseline and immediately after intervention/control)

    Plasma epinephrine concentrations will be measured in duplicate using a commercially available enzyme-linked immunosorbent assay (ELISA) kit.

    Measured: Baseline and immediately after intervention/control.

  2. Epinephrine (change between baseline and 15 minutes after intervention/control)

    Plasma epinephrine concentrations will be measured in duplicate using a commercially available enzyme-linked immunosorbent assay (ELISA) kit.

    Measured: Baseline and 15 minutes after intervention/control.

  3. Epinephrine (change between baseline and 30 minutes after intervention/control)

    Plasma epinephrine concentrations will be measured in duplicate using a commercially available enzyme-linked immunosorbent assay (ELISA) kit.

    Measured: Baseline and 30 minutes after intervention/control.

  4. Epinephrine (change between baseline and 45 minutes after intervention/control)

    Plasma epinephrine concentrations will be measured in duplicate using a commercially available enzyme-linked immunosorbent assay (ELISA) kit.

    Measured: Baseline and 45 minutes after intervention/control.

  5. Epinephrine (change between baseline and 60 minutes after intervention/control)

    Plasma epinephrine concentrations will be measured in duplicate using a commercially available enzyme-linked immunosorbent assay (ELISA) kit.

    Measured: Baseline and 60 minutes after intervention/control.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2022
  2. Study start1 Jun 2022 (estimated)
  3. Primary completion30 Sep 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05407259
Sponsor's protocol ID
202205HM003
Status last verified
Jun 2022
First submitted
26 May 2022
Last updated
9 Jun 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will publish the raw data online when we submit the resulting manuscript.

Questions about this trial

What is this clinical trial studying?

A study testing Resistance exercise in people with Healthy Young Adults, run by National Taiwan Normal University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ting-Yu Lin, B.A. (+886975211701, leo850922@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inhibitory control (change between baseline and 5 minutes after intervention/control) (time frame: Baseline (before intervention) and 5 minutes after (post-task) intervention/control.). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in